S&P Affirms Illinois Dev Fin Auth Revs 'BBB-' Rating Dec 98

  • ID: 1721848
  • December 1998
  • Region: Illinois
  • Standard & Poors
1 of 3

NY -- Standard & Poor's CreditWire 12/8/98 – Standard & Poor's today affirmed its triple-'B'-minus rating on Illinois Development Finance Authority's housing revenue bonds (Sandwich Apts Project.) The rating and outlook on the bonds issued for Sandwich Apartments are affirmed pending a proposed change in partnership interest and proposed change in management of the property. The rating reflects: -- Debt service coverage of 1.16 times (x), -- Sufficiency of reserves, -- Quality of investments, and -- Proposed changes in management and ownership of the property. Casden Properties GP II Limited Partnership plans to acquire the general partner interest under the terms of the Limited Partnership Agreement for Sandwich Apartments Associates, II Limited Partnership. Simultaneously, HAPI Management Inc. will assume management...

Companies mentioned in this report are:
- Illinois Fin Auth

Action: Affirmed

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Illinois Fin Auth

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.